PharmChem (PharmChem) Retained Earnings : $-10.58 Mil (As of Sep. 2023)

View and export this data going back to 2003. Start your Free Trial

What is PharmChem Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. PharmChem's retained earnings for the quarter that ended in Sep. 2023 was $-10.58 Mil.

PharmChem's quarterly retained earnings increased from Sep. 2003 ($-10.28 Mil) to Sep. 2022 ($0.00 Mil) but then declined from Sep. 2022 ($0.00 Mil) to Sep. 2023 ($-10.58 Mil).

PharmChem's annual retained earnings declined from Dec. 2000 ($0.00 Mil) to Dec. 2001 ($-12.58 Mil) but then increased from Dec. 2001 ($-12.58 Mil) to Dec. 2002 ($-9.24 Mil).

PharmChem Retained Earnings Historical Data

The historical data trend for PharmChem's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmChem Retained Earnings Chart

PharmChem Annual Data

Trend

Dec93

Dec94

Dec95

Dec96

Dec97

Dec98

Dec99

Dec00

Dec01

Dec02

Retained Earnings

Get a 7-Day Free Trial

-8.30

-5.46

-12.58

-9.24

PharmChem Quarterly Data
	Jun99	Sep99	Dec99	Mar00	Jun00	Sep00	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Sep22	Sep23
Retained Earnings	Get a 7-Day Free Trial															-9.97	-10.52	-10.28	-	-10.58

PharmChem Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

PharmChem (OTCPK:PCHM) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

PharmChem (PharmChem) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PharmChem Inc (OTCPK:PCHM) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

2411 E. Loop 820 N, Fort Worth, TX, USA, 76118

Website

https://www.pharmchek.com

PharmChem Inc is engaged in selling and distributing of the PharmChek Sweat Patch Device. PharmChek is a system that uses sweat to detect the presence of illegal drugs. It consists of a transparent polyurethane outer covering, a small absorbent pad, and a release liner. Geographically the activities are carried out throughout the United States.

Executives

Alto Investors Palo	10 percent owner	470 UNIVERSITY AVENUE, PALO ALTO CA 94301
Micro Cap Partners Lp	10 percent owner

PharmChem (PharmChem) Headlines

From GuruFocus

PharmChem (PCHM) Announces Response To Opposition

By PRNewswire PRNewswire • 08-11-2021